Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
Autor: | Wetzel, Lisa A., Hurtado, Myrna, MacDowell Kaswan, Zoe A., McCusker, Robert H., Steelman, Andrew J. |
---|---|
Zdroj: | In Brain, Behavior, & Immunity - Health August 2020 7 |
Databáze: | ScienceDirect |
Externí odkaz: |